Ensign Peak Advisors’s Skye Bioscience SKYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.21M Hold
767,287
0.01% 745
2025
Q1
$1.22M Hold
767,287
﹤0.01% 1136
2024
Q4
$2.17M Sell
767,287
-132,713
-15% -$376K ﹤0.01% 902
2024
Q3
$3.52M Buy
+900,000
New +$3.52M 0.01% 746